The E-CloudBind framework combines electron cloud representations with molecular graphs to predict drug-protein interactions. This approach maintains accuracy even when using low-resolution or out-of-distribution structures. It solves a critical stability gap in current molecular modeling. Researchers can now identify viable drug candidates with fewer high-resolution crystals.